Evolution Wealth Advisors, LLC Seres Therapeutics, Inc. Transaction History

Evolution Wealth Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$6.02 - $11.43 $4,502 - $8,549	-748 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$5.46 - $22.6 $1,195 - $4,949	219 Added 41.4%	748 $5,000
Q2 2021 Jul 22, 2021	BUY	$18.46 - $24.36 $996 - $1,315	54 Added 11.37%	529 $13,000
Q1 2021 Apr 20, 2021	BUY	$17.66 - $28.92 $1,924 - $3,152	109 Added 29.78%	475 $10,000
Q4 2020 Feb 02, 2021	BUY	$23.25 - $37.73 $8,509 - $13,809	366 New	366 $9,000

46.3M

119K

466K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $118M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.